Guidance for market authorization requirements for COVID-19 drugs: Overview
Description
This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.
Resources
| Name |
Format |
Description |
Link |
| Guidance for market authorization requirements for COVID-19 drugs: Overview |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines.html |
| Guidance for market authorization requirements for COVID-19 drugs: Overview |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines.html |